147 related articles for article (PubMed ID: 12550756)
1. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
3. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
5. Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.
Uribe P; Wistuba II; Gonzalez S
Am J Dermatopathol; 2009 Jun; 31(4):354-63. PubMed ID: 19461239
[TBL] [Abstract][Full Text] [Related]
6. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of allelic deletions within melanoma metastases.
Bogdan I; Xin H; Burg G; Böni R
Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
[TBL] [Abstract][Full Text] [Related]
8. Spitz nevi display allelic deletions.
Bogdan I; Burg G; Böni R
Arch Dermatol; 2001 Nov; 137(11):1417-20. PubMed ID: 11708943
[TBL] [Abstract][Full Text] [Related]
9. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
Indsto JO; Cachia AR; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
[TBL] [Abstract][Full Text] [Related]
10. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
Takata M; Morita R; Takehara K
Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi.
Maitra A; Gazdar AF; Moore TO; Moore AY
Hum Pathol; 2002 Feb; 33(2):191-7. PubMed ID: 11957144
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
13. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma.
Rao UN; Bakker A; Swalsky PA; Finkelstein SD
Mod Pathol; 1999 Apr; 12(4):344-50. PubMed ID: 10229497
[TBL] [Abstract][Full Text] [Related]
14. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
15. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanocytomas: genetic comparison with uveal and dermal melanomas.
Fogt F; Selim AM; Xu GX; Prinz MK; Eagle RC; Budimlija ZM
Arch Ophthalmol; 2005 Mar; 123(3):377-80. PubMed ID: 15767481
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and loss of heterozygosity in melanoma.
Peris K; Keller G; Chimenti S; Amantea A; Kerl H; Höfler H
J Invest Dermatol; 1995 Oct; 105(4):625-8. PubMed ID: 7561170
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas.
Kumar R; Smeds J; Lundh Rozell B; Hemminki K
Melanoma Res; 1999 Apr; 9(2):138-47. PubMed ID: 10380936
[TBL] [Abstract][Full Text] [Related]
19. Melanoma ex naevo: a study of the associated naevus.
Bogdan I; Smolle J; Kerl H; Burg G; Böni R
Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region.
Poetsch M; Dittberner T; Woenckhaus C
Melanoma Res; 2003 Feb; 13(1):29-33. PubMed ID: 12569282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]